Ausgabe 3/2010
Inhalt (10 Artikel)
Editorial
Future challenges for health economics and health technology assessment of biological drugs
László Gulácsi
Original Paper
BMI and Spanish labour status: evidence by gender from the city of Barcelona
Toni Mora
Original Paper
The impact of missing data in the estimation of concentration index: a potential source of bias
Hai Zhong
Original Paper
The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany
Tom Stargardt
Original Paper
Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: hospital-level prescription of thiazolidinediones for diabetes
Yi-Wen Tsai, Yu-Wen Wen, Weng-Foung Huang, Ken N. Kuo, Pei-Fen Chen, Hsin-Wei Shih, Yue-Chune Lee
Open Access
Original Paper
Principal agent relationships and the efficiency of hospitals
Martijn Ludwig, Frits Van Merode, Wim Groot
Original Paper
The welfare costs of HIV/AIDS in Eastern Europe: an empirical assessment using the economic value-of-life approach
Julia Fimpel, Michael Stolpe
Original Paper
Eliciting health state utilities from the general public for severe chronic pain
S. Eldabe, A. Lloyd, L. Verdian, M. Meguro, G. Maclaine, S. Dewilde
Original Paper
Copayments for ambulatory care in Germany: a natural experiment using a difference-in-difference approach
Jonas Schreyögg, Markus M. Grabka
Pricing and reimbursement systems in Europe
The Irish ‘health basket’: a basket case?
Samantha Smith